These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15004017)

  • 1. Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice.
    Assem M; Schuetz EG; Leggas M; Sun D; Yasuda K; Reid G; Zelcer N; Adachi M; Strom S; Evans RM; Moore DD; Borst P; Schuetz JD
    J Biol Chem; 2004 May; 279(21):22250-7. PubMed ID: 15004017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis.
    Chai J; Luo D; Wu X; Wang H; He Y; Li Q; Zhang Y; Chen L; Peng ZH; Xiao T; Wang R; Chen W
    J Gastrointest Surg; 2011 Jun; 15(6):996-1004. PubMed ID: 21359593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat.
    Denk GU; Soroka CJ; Takeyama Y; Chen WS; Schuetz JD; Boyer JL
    J Hepatol; 2004 Apr; 40(4):585-91. PubMed ID: 15030973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.
    Kim MS; Shigenaga J; Moser A; Grunfeld C; Feingold KR
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E731-8. PubMed ID: 15198932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter.
    Renga B; Migliorati M; Mencarelli A; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
    Biochim Biophys Acta; 2011 Mar; 1809(3):157-65. PubMed ID: 21296199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
    Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
    J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
    Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
    Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
    Chen P; Zeng H; Wang Y; Fan X; Xu C; Deng R; Zhou X; Bi H; Huang M
    Drug Metab Dispos; 2014 May; 42(5):844-52. PubMed ID: 24510383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
    Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
    Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids.
    Marschall HU; Wagner M; Bodin K; Zollner G; Fickert P; Gumhold J; Silbert D; Fuchsbichler A; Sjövall J; Trauner M
    J Lipid Res; 2006 Mar; 47(3):582-92. PubMed ID: 16327028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice.
    Chen P; Li D; Chen Y; Sun J; Fu K; Guan L; Zhang H; Jiang Y; Li X; Zeng X; Chen X; Huang M; Bi H
    Br J Pharmacol; 2017 Dec; 174(23):4345-4361. PubMed ID: 28910492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
    Zelcer N; Reid G; Wielinga P; Kuil A; van der Heijden I; Schuetz JD; Borst P
    Biochem J; 2003 Apr; 371(Pt 2):361-7. PubMed ID: 12523936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFα Induces Multidrug Resistance-Associated Protein 4 Expression through p38-E2F1-Nrf2 Signaling in Obstructive Cholestasis.
    Lian W; Liu X; Chen W
    Yonsei Med J; 2019 Nov; 60(11):1045-1053. PubMed ID: 31637886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice.
    Beilke LD; Aleksunes LM; Holland RD; Besselsen DG; Beger RD; Klaassen CD; Cherrington NJ
    Drug Metab Dispos; 2009 May; 37(5):1035-45. PubMed ID: 19196849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
    Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle.
    De Fabiani E; Mitro N; Gilardi F; Caruso D; Galli G; Crestani M
    J Biol Chem; 2003 Oct; 278(40):39124-32. PubMed ID: 12865425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
    Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.
    Bohan A; Chen WS; Denson LA; Held MA; Boyer JL
    J Biol Chem; 2003 Sep; 278(38):36688-98. PubMed ID: 12837754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity.
    Zhang J; Huang W; Qatanani M; Evans RM; Moore DD
    J Biol Chem; 2004 Nov; 279(47):49517-22. PubMed ID: 15358766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.